Compare Vaxcyte Inc. Common Stock (PCVX) vs Rackspace Technology Inc. Common Stock (RXT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Rackspace Technology Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Rackspace Technology Inc. Common Stock trades at $3.11 (market cap $925.19M). The key difference: Vaxcyte Inc. Common Stock is far larger — about 11.4× Rackspace Technology Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Rackspace Technology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Rackspace Technology Inc. Common Stock for 0 Days on average.
| PCVX | RXT | |
|---|---|---|
Market Cap | $10.51B | $925.19M |
Volume | 2,644,694 | 2,631,364 |
Sector | Health | Technology |
52-Week High | $73.82 | $7.53 |
52-Week Low | $40.32 | $0.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $4.09B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Rackspace Technology Inc. Common Stock
Rackspace Technology, Inc. provides managed multicloud and hybrid cloud services, helping organizations design, operate, and support workloads across AWS, Microsoft Azure, Google Cloud, and private infrastructure.
Read more on RXT →
